Works matching Castration

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 479, doi. 10.1007/s10147-019-01541-8
    By:
    • Mori, Keiichiro;
    • Kimura, Takahiro;
    • Fukuokaya, Wataru;
    • Iwatani, Kosuke;
    • Sakanaka, Keigo;
    • Kurokawa, Gaku;
    • Yanagisawa, Takafumi;
    • Sasaki, Hiroshi;
    • Miki, Jun;
    • Shimomura, Tatsuya;
    • Miki, Kenta;
    • Hatano, Takashi;
    • Endo, Katsuhisa;
    • Egawa, Shin
    Publication type:
    Article
    12

    Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data.

    Published in:
    Current Medical Research & Opinion, 2021, v. 37, n. 4, p. 609, doi. 10.1080/03007995.2021.1879753
    By:
    • Freedland, Stephen J.;
    • Ke, Xuehua;
    • Lafeuille, Marie-Hélène;
    • Romdhani, Hela;
    • Kinkead, Frederic;
    • Lefebvre, Patrick;
    • Petrilla, Allison;
    • Pulungan, Zul;
    • Kim, Seung;
    • D'Andrea, Denise M.;
    • Francis, Peter;
    • Ryan, Charles J.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.

    Published in:
    BMC Urology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12894-022-01096-3
    By:
    • Sugimoto, Mikio;
    • Kato, Takuma;
    • Tohi, Yoichiro;
    • Shimizu, Yosuke;
    • Matsumoto, Ryuji;
    • Inoue, Takahiro;
    • Takezawa, Yutaka;
    • Masui, Kimihiko;
    • Sasaki, Hiroshi;
    • Hirama, Hiromi;
    • Saito, Shiro;
    • Egawa, Shin;
    • Kamoto, Toshiyuki;
    • Teramukai, Satoshi;
    • Kojima, Shinsuke;
    • Kikuchi, Takashi;
    • Kakehi, Yoshiyuki
    Publication type:
    Article
    21
    22
    23

    Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.

    Published in:
    World Journal of Urology, 2022, v. 40, n. 10, p. 2459, doi. 10.1007/s00345-022-04108-x
    By:
    • Angulo, J. C.;
    • Ciria Santos, J. P.;
    • Gómez-Caamaño, A.;
    • Poza de Celis, R.;
    • González Sala, J. L.;
    • García Garzón, J. M.;
    • Galán-Llopis, J. A.;
    • Pérez Sampietro, M.;
    • Perrot, V.;
    • Planas Morin, J.;
    • on behalf of ANARESISTANCE study group;
    • Abascal, José Manuel;
    • Barrond, Víctor;
    • Benedicto, Antonio;
    • Carballo, Ana;
    • Cortiñas, José Ramón;
    • Fernández, Manuel;
    • Ferrer, Eduardo;
    • Guzmán, Pablo Luís;
    • López, Miguel Ángel
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 427, doi. 10.1007/s10147-022-02288-5
    By:
    • Oka, Toshiki;
    • Hatano, Koji;
    • Okuda, Yohei;
    • Yamamoto, Akinaru;
    • Uemura, Toshihiro;
    • Yamamichi, Gaku;
    • Tomiyama, Eisuke;
    • Ishizuya, Yu;
    • Yamamoto, Yoshiyuki;
    • Kato, Taigo;
    • Kawashima, Atsunari;
    • Fujita, Kazutoshi;
    • Nonomura, Norio
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study.

    Published in:
    International Journal of Urology, 2020, v. 27, n. 7, p. 610, doi. 10.1111/iju.14258
    By:
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Takahashi, Masahiro;
    • Sakurai, Toshihiko;
    • Kawamura, Sadafumi;
    • Hoshi, Senji;
    • Ishida, Masanori;
    • Kawaguchi, Toshiaki;
    • Ishidoya, Shigeto;
    • Shimoda, Jiro;
    • Sato, Hiromi;
    • Hamano, Itsuto;
    • Okamoto, Teppei;
    • Mitsuzuka, Koji;
    • Ito, Akihiro;
    • Tsuchiya, Norihiko;
    • Arai, Yoichi;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    50